The Christie Charity
The list below shows The Lymphoma Group's current clinical trials open for recruitment for follicular lymphoma patients.
If you would like to know how to access our trials, please see how to contact us.
- PETReA - A phase 3 trial testing whether PET scans can help make treatment decisions for people with follicular lymphoma
Suitable for patients who haven't yet received any treatment - CCS1477-02 - A phase 1/2a study of CCS1477 in blood cancers, including relapsed or refractory non-Hodgkin lymphoma.
- StepPharma/STP938 – Testing STP938 in people with T-cell and B-cell lymphomas that has relapsed or is refractory
- MK1026-003 - A trial of MK-1026 for some types of blood cancer, including follicular lymphoma
- REFRACT – a randomised trial of standard therapy vs new therapy experimental arms
- NX-5948-301 – Testing NX-5948 in patients with relapsed or refractory B cell lymphoma including follicular lymphoma
- ZUMA-22 – a randomised trial of CAR-T (Axi-cel) vs standard therapy
- BYON4228.001 - A phase 1 trial of BYON4228 in patients with relapsed or refractory B-cell non-Hodgkin lymphoma
- Mahogany - A phase 3 trial of zanubrutinib and anti-CD20 in people with relapsed or refractory follicular or marginal zone lymphoma
- waveLINE-003 - A trial testing zilovertamab vedotin (MK-2140) in people with relapsed or refractory follicular lymphoma
- M23-324 - Phase 1 trial of ABBV-525 in people with B-cell lymphomas
With special thanks to the following:
For further information on each trial, please visit the Find a trial page on Lymphoma Action’s website.